• We have ensured world-class quality in design, equipment and operations in all our contract manufacturing facilities. Our contract manufacturing facilities are state-of-the-art manufacturing facilities. These manufacturing units are located in vishakapatnam.
  • Our manufacturing operations are focused on producing generics, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates in the full range
  • We have a highly skilled team of regulatory affairs specialists who are well versed with regulatory policies and procedures around the world. They have a wealth of experience in the timely filing of dossiers as well as handling regulatory queries from both authorities and customers.
  • A wide range of regulatory agencies routinely conduct stringent audits of our manufacturing facilities for compliance with Current Good Manufacturing Practices (cGMP). Several regulatory agencies, including KFDA-Korea/WHO GMP/ISO standards.
  • Hubert plans to start manufacturing operations from in-house facilities by 2022.

Capabilities of our contract manufacturing plants include

Reactors ranging from 100lit to 10KL which includes 60% of them accounting to SSRS and rest for GLRS.

In house Nitrogen plant facilities

Dedicated clean rooms for APIS and advanced intermediates

  • Dedicated pilot plants for scale-up studies
  • Wide range of analytical equipment including GCs, HPLCs with PDA, IR,
  • Dedicated Solvent recovery Plant
  • Well-equipped Effluent Treatment Plant
  • Hydrogenation facility
  • Purified water generation & distribution system
  • 100% compliance to Environment, Health & Safety
  • Sampling and dispensing booth for Raw Material (RLAF)

Quality Control

  • Well equipped testing laboratory containing Wet lab, Instrumentation & Microbiology lab
  • Wide range of analytical equipment including GCs, HPLCs with PDA, IR,
  • Analysis of Raw materials, In-process & Intermediates and APIs
  • Stability studies as per global requirements
  • Storage of retained samples

Our Approach

Strategic partnerships are an integral component of the company’s growth strategy. We focus on developing products with significant barriers for entry and those have longer lifecycle. We continue to build and foster strategic business alliances with major pharmaceutical companies and service providers in Win-Win environment.

We have a long tradition of successful collaborations. Our approach to partnerships has been path-breaking and successful in the Indian pharmaceutical industry in terms of product and market coverage while leveraging each other’s partnership strengths. They are an essential and integral part of our research and business strategy. Every day, we commit ourselves to aligning our capabilities with business opportunities and everything we do is based on being easy to work with and ensure win-win strategies.

Hubert has emerged as a full-fledged pharmaceutical corporation with end-to-end connectivity from initial product development to delivery. Each alliance we build is based on a shared vision with well-defined goals and objectives. We have the ability to leverage and represent our entire portfolio of products and services based on their core competencies, partner great models, build and sustain operations. By pooling the talents of our science and business teams, we have engaged in significant number of collaborations with domestic and international companies. We look to build upon our existing strengths as well as to create new areas of expertise to take up any challenges that we may come across.

We are thus ideally positioned to be a partner of choice for global product development and manufacturing outsourcing solutions under single roof.